JPH09249578A - Clinical application of crude drug extract with tyrosinase activation as an index - Google Patents

Abstract

(57) [Abstract] [Problem] Conventional tyrosinase activating action has been imparted by caffeic acid, chlorogenic acid or their derivatives, but they still have insufficient points. SOLUTION: The above-mentioned disadvantage is one of 56 kinds according to claim 1.
Substituting and using the herbal extract (s) for the seed (s), improved and realized potent tyrosinase activating properties. [Effect] By using the above-mentioned herbal medicine extract having a strong tyrosinase activating effect, an anti-white spot and / or anti-hair graying agent could be provided.

Description

Detailed Description of the Invention

[0001]

TECHNICAL FIELD The present invention relates to a tyrosinase activator using one or more of the following 56 herbal extracts, and an anti-white spot therapeutic agent and / or anti-white hair containing at least one of them. Regarding therapeutic agents. Table 1 shows the names of these crude drugs
Are listed.

[Table 1]

[Table 2]

[Table 3]

[0002]

2. Description of the Related Art The present inventors have previously described caffeic acid.
acid) and its derivatives have a tyrosinase activating effect and are effective for the treatment of anti-white spots and anti-hair graying.
However, they were also found to have the following disadvantages. Therefore, the present inventors have aimed to develop a more effective therapeutic drug.

[0003]

[Problems to be Solved by the Invention] For the tyrosinase activating effect of caffeic acid or chlorogenic acid (Chlorogenic acid) and their derivatives, a concentration-action curve is required between certain concentrations, but the action decreases rather than a certain concentration. To do. That is, there is a maximum value in the action, and a stronger action cannot be obtained. This development was intended to break the bottleneck.

[0004]

[Means for Solving the Problems] Extracts of crude drugs contain a number of complex components, and have a different action from the individual actions of these components or a powerful action far exceeding the individual actions. It is known to present. Based on this experience
We turned to the tyrosinase activating action of extracts of crude drugs. Many crude drugs having caffeic acid, chlorogenic acid and their derivatives are known. The present inventors have completed the present invention by discovering that the tyrosinase activating action of these extracts is so strong that it cannot be explained by the action of caffeic acid, chlorogenic acid or its derivatives.

[0005]

BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be specifically described with reference to the embodiments of the present invention.

Example 1 A measurement system for tyrosinase activation activity was set as shown in Table 2.
As tyrosinase, mushroom-derived Sigma manufactured by Sigma was used.

[0007]

[Table 4] * Ec: Control absorbance at A475, A580nm A2min.-A0min. Es: Sample absorbance at A475, A580nm A2min.-A0min.

Example 2 The tyrosinase activating effect of a crude drug extract containing a derivative of caffeic acid / chlorogenic acid was measured. A part of them is summarized as a graph in FIG. Extraction is 50% ethanol, 10
It was carried out with 3 solvents of 0% ethanol and ethyl acetate.
The extract with 50% ethanol was the most effective for all crude drugs.

Example 3 The activating effect of these crude drug extracts was compared with that of caffeic acid and chlorogenic acid. And the hypothesis was substantiated.
See [Table 3].

[0010]

[Table 5] * All sample concentrations were 0.1%.

Example 4 An anti-alcoholic disease therapeutic agent was prepared according to the following formulation. <Tonic> Continuous 50% ethanol extract 0.5% Carpronium chloride 1.0% Benzyl nicotinate 0.05% 50% Ethanol / buffer ^* Proper amount 100ml * Sodium citrate / HCl buffer (pH 4.8 ~ 5.0)

Example 5 An anti-baldew treatment agent was prepared according to the following formulation. <Tonic> Labyrinth 50% ethanol extract or summer hay extract 0.5% Benzyl nicotinate 0.05% Cemblyx extract 0.1% Side Kashiwa leaf extract A 0.1% (Carpronium chloride 0.1%) 50% Ethanol / buffer ^* Proper amount 100ml * Citric acid Sodium / HCl buffer (pH 4.8 ~ 5.0)

Example 6 An anti-white spot therapeutic agent was prepared according to the following formulation. <Liquid formulation> 50% ethanol extract or 0.5% carpronium chloride 3 to 5.0% 1,3-butylene glycol 40.0% 20% ethanol / buffer solution ^* Proper amount 100 ml * Sodium citrate / HCl buffer solution (pH 4.8) ~ 5.0)

Example 7 An anti-white spot disease therapeutic agent was prepared according to the following formulation. <Ointment> 50% ethanol extract with continuous scent or camouflage scent 0.5g Carpronium chloride 3.0g 1,3-Butylene glycol 20.0g Hydrophilic poloid 100g

[Brief description of drawings]

FIG. 1 is a graph showing the results of measuring the tyrosinase activation effect of crude drug extracts in Examples.

─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. ⁶ Identification number Internal reference number FI Technical indication location A61K 35/78 A61K 35/78 J K N Q S T V ADA ADAH ADS ADSR 7/00 7/00 K X 7/06 7/06

Claims (2)

[Claims] 1. Extracts of the following 56 kinds of crude drugs having tyrosinase activating action as a powerful property: [External 1] 2. One or two of the crude drug extracts according to claim 1.
Anti-white spot and / or containing at least one species
Anti-grey hair treatment agent.